,43 In a mouse model of Fragile X syndrome, loss of translational control of matrix metalloproteinase-9 (MMP9) contributed to the disease phenotype, such as delayed dendritic spine maturation.44 This evidence concerns the gene MMP9 and fragile X syndrome.